Author: Michael Jannicelli
The BOOM-IBD Clinical Trial
Posted by Michael Jannicelli | Oct 20, 2023 | Uncategorized | 0 |
BOOM-IBD Clinical Trial If you have Inflammatory Bowel Disease (IBD) and are looking for answers,...
Read MoreNew ‘subway map’ of Lyme disease pathways identifies potential new treatment targets
Posted by Michael Jannicelli | Oct 20, 2023 | Uncategorized | 0 |
Scientists have developed a genome-scale metabolic model or ‘subway map’ of key...
Read MoreI am now in remission
Posted by Michael Jannicelli | Oct 20, 2023 | Uncategorized | 0 |
Hi, I’m new to the board but I felt obliged to join and post what worked for me as my chrons...
Read MoreTakeda’s stem cell treatment Alofisel flunks phase 3 trial in Crohn’s complication
Posted by Michael Jannicelli | Oct 20, 2023 | Uncategorized | 0 |
Takeda’s stem cell treatment Alofisel flunks phase 3 trial in Crohn’s complication After...
Read MoreRecent Posts
- Survey finds 25% of adults suspect they have undiagnosed ADHD
- Friendships: Enrich your life and improve your health
- Eli Lilly’s Omvoh (mirikizumab) beats J&J’s Stelara in head-to-head study
- Current research opportunity on IBD and LGB people in the UK
- A potential non-invasive stool test and novel therapy for endometriosis
Recent Comments
No comments to show.